Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.13
0.06 (0.11%)
At close: Aug 18, 2025, 3:59 PM
56.21
0.14%
After-hours: Aug 18, 2025, 04:42 PM EDT
Protagonist Therapeutics Revenue
Protagonist Therapeutics reported an annual revenue of $434.43M, reflecting a 624.05% growth. For the quarter ending June 30, 2025, Protagonist Therapeutics generated $0 in revenue.
Revenue (ttm)
434.43M
Revenue Growth
624.05%
Price / Sales Ratio
5.47
Revenue / Employee
3.5M
Employees
124
Market Cap
3.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 434.43M | +624.05% |
| Dec 31, 2023 | 60M | +125.73% |
| Dec 31, 2022 | 26.58M | -2.84% |
| Dec 31, 2021 | 27.36M | -4.44% |
| Dec 31, 2020 | 28.63M | +12293.07% |
| Dec 31, 2019 | 231K | -99.25% |
| Dec 31, 2018 | 30.93M | +54.14% |
| Dec 31, 2017 | 20.06M | +Infinity% |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |